# China NMPA Drug Inspection - Ruiyang Pharmaceutical Co., Ltd. - Ranitidine Hydrochloride Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/ruiyang-pharmaceutical-co-ltd/e55df127-7ff3-409d-ba9f-e38763b700a0/
Source feed: China

> China NMPA drug inspection for Ruiyang Pharmaceutical Co., Ltd. published June 01, 2016. Drug: Ranitidine Hydrochloride Capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shandong Province Drug Quality Bulletin (Issue 5, 2016)
- Company Name: Ruiyang Pharmaceutical Co., Ltd.
- Publication Date: 2016-06-01
- Drug Name: Ranitidine Hydrochloride Capsules
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/ruiyang-pharmaceutical-co-ltd/9483ad2c-e2a5-433c-96c9-a6e7b10b6ecb/